Download PDF

Journal of Viral Hepatitis

Publication date: 2016-07-01
Volume: 23 Pages: 512 - 521
Publisher: Blackwell Science

Author:

Drave, SA
Debing, Yannick ; Walter, S ; Todt, D ; Engelmann, M ; Friesland, M ; Wedemeyer, H ; Neyts, Johan ; Behrendt, P ; Steinmann, E

Keywords:

Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology, Infectious Diseases, Virology, extra-hepatic manifestation, Hepatitis E Virus (HEV), neurologic disorders, neuronal-derived cells, ribavirin, viral replication, GUILLAIN-BARRE-SYNDROME, TRANSPLANT RECIPIENTS, NEURALGIC AMYOTROPHY, NEUROLOGIC DISORDERS, IN-VITRO, RIBAVIRIN, Cell Line, Hepatitis E virus, Humans, Neuroglia, Neurons, Viral Tropism, Virus Replication, 0605 Microbiology, 1103 Clinical Sciences, 1108 Medical Microbiology, 3202 Clinical sciences, 3207 Medical microbiology

Abstract:

Hepatitis E virus (HEV) is the causative agent of hepatitis E in humans and a member of the genus Orthohepevirus in the family Hepeviridae. Infection usually leads to acute hepatitis that can become fulminant, particularly among pregnant women and in patients with preexisting liver disease, or may evolve to a chronic state, especially in immunosuppressed individuals. HEV has been shown to produce a range of extra-hepatic manifestations including aplastic anaemia, acute thyroiditis, glomerulonephritis as well as neurological disorders such as Guillain-Barré syndrome, neuralgic amyotrophy and encephalitis. The pathogenesis of these neurological injuries remains largely unknown, and it is also uncertain whether or not HEV can directly infect neuronal cells. In this study, we investigated whether HEV is capable of completing the viral life cycle in human neuronal-derived cell lines such as neuroepithelioma (SK-N-MC), desmoplastic cerebellar medulloblastoma (DAOY), glioblastoma multiforme (DBTRG), glioblastoma astrocytoma (U-373 MG) and oligodendrocytic (M03.13) cells. Following transfection of these cells with HEV Gaussia luciferase reporter virus, all tested cell lines supported HEV RNA replication. Furthermore, extra- and intracellular viral capsid was detected by an HEV antigen ELISA as a marker for virus assembly and release. Permissiveness for HEV cell entry could be demonstrated for the oligodendrocytic cell line M03.13. In conclusion, these results indicate that HEV tropism is not restricted to the liver and HEV can potentially complete the full viral life cycle in neuronal-derived tissues explaining neurologic disorders during HEV infection.